{
  "value_claims": [
    {
      "id": "VC-002",
      "claim_title": "Dose ID GPT optimizes vaccine dose selection from thousands of pages",
      "claim_description": "Dose ID GPT analyzes large clinical datasets to recommend optimal vaccine doses and provide rationale, supporting clinical study teams before advancing doses to testing.",
      "source_ids": [
        "S3"
      ],
      "source_quote": "Dose ID GPT really allows us to take these large data sets ... and input that into the GPT, which makes an optimal dose recommendation from thousands of pages of data",
      "quote_location": "Meklit Workneh quote, paragraph 5",
      "ai_attribution": "direct",
      "attribution_evidence": "The GPT directly performs the analysis and generates dose recommendations with supporting rationale.",
      "verification_status": "verified",
      "evidence_level": "method",
      "evidence_grade": "primary",
      "application_type": "capability_enhancement",
      "mechanism": [
        "optimization",
        "augmentation"
      ],
      "outcome": [
        "velocity"
      ],
      "cognitive_depth": "prescriptive",
      "metric_raw": null,
      "metric_classification": null,
      "ontology_version": "1.0",
      "ontology_confidence": null,
      "human_validation": {
        "reviewed": false,
        "reviewer_verdict": null,
        "attribution_correct": null,
        "attribution_override": null,
        "missed_claim": false,
        "review_notes": null,
        "review_date": null,
        "reviewer_id": null
      }
    },
    {
      "id": "VC-004",
      "claim_title": "mRNA Design Studio enables rapid parallel design of multiple mRNA sequences",
      "claim_description": "Cloud-based mRNA Design Studio uses proprietary algorithms to automatically convert protein targets to optimized mRNA sequences and enables parallel intake and design of multiple sequences.",
      "source_ids": [
        "S4"
      ],
      "source_quote": "The utility of cloud-based capacity allows us to provide flexible computational capacity on demand. This allows the Research Engine to power parallel intake and design of multiple mRNA sequences.",
      "quote_location": "Parallel design section",
      "ai_attribution": "direct",
      "attribution_evidence": "The digital design tools directly perform the mRNA sequence optimization and enable parallel processing capabilities.",
      "verification_status": "verified",
      "evidence_level": "method",
      "evidence_grade": "primary",
      "application_type": "capability_creation",
      "mechanism": [
        "automation",
        "optimization"
      ],
      "outcome": [
        "velocity"
      ],
      "cognitive_depth": "prescriptive",
      "metric_raw": null,
      "metric_classification": null,
      "ontology_version": "1.0",
      "ontology_confidence": null,
      "human_validation": {
        "reviewed": false,
        "reviewer_verdict": null,
        "attribution_correct": null,
        "attribution_override": null,
        "missed_claim": false,
        "review_notes": null,
        "review_date": null,
        "reviewer_id": null
      }
    },
    {
      "id": "VC-006",
      "claim_title": "Research Engine accelerates programs from idea to development candidate",
      "claim_description": "Research Engine combines proprietary digital drug design tools and automated production to enable rapid supply of thousands of pre-clinical mRNAs, accelerating advancement from concept to candidate.",
      "source_ids": [
        "S4"
      ],
      "source_quote": "Our infrastructure enables rapid supply of thousands of pre-clinical mRNAs for in vitro and in vivo research to accelerate programs from idea to development candidate designation.",
      "quote_location": "Our Research Engine section",
      "ai_attribution": "direct",
      "attribution_evidence": "Digital drug design tools are explicitly identified as core components enabling the acceleration capability.",
      "verification_status": "verified",
      "evidence_level": "method",
      "evidence_grade": "primary",
      "application_type": "capability_creation",
      "mechanism": [
        "automation",
        "optimization"
      ],
      "outcome": [
        "velocity"
      ],
      "cognitive_depth": "prescriptive",
      "metric_raw": null,
      "metric_classification": null,
      "ontology_version": "1.0",
      "ontology_confidence": null,
      "human_validation": {
        "reviewed": false,
        "reviewer_verdict": null,
        "attribution_correct": null,
        "attribution_override": null,
        "missed_claim": false,
        "review_notes": null,
        "review_date": null,
        "reviewer_id": null
      }
    }
  ],
  "context_claims": [
    {
      "id": "CC-001",
      "context_type": "organisational",
      "claim_title": "Moderna is a biotechnology company focused on mRNA therapeutics",
      "claim_description": "Moderna develops mRNA-based vaccines and therapeutics for infectious diseases, cancer, and metabolic diseases.",
      "source_ids": [
        "S3",
        "S4"
      ],
      "source_quote": "The biotechnology company on Wednesday said it has expanded a partnership with OpenAI",
      "verification_status": "verified",
      "verification_confidence": "high",
      "inferred_from": null,
      "apqc_code": null,
      "apqc_name": null,
      "human_validation": {
        "reviewed": false,
        "reviewer_verdict": null,
        "attribution_correct": null,
        "attribution_override": null,
        "missed_claim": false,
        "review_notes": null,
        "review_date": null,
        "reviewer_id": null
      }
    },
    {
      "id": "CC-002",
      "context_type": "temporal",
      "claim_title": "Moderna-OpenAI partnership began in 2023",
      "claim_description": "Moderna and OpenAI have been working together since last year (relative to 2024 announcement).",
      "source_ids": [
        "S3"
      ],
      "source_quote": "The companies have been working together since last year and Moderna employees were already using a chatbot built around ChatGPT.",
      "verification_status": "verified",
      "verification_confidence": "high",
      "inferred_from": null,
      "apqc_code": null,
      "apqc_name": null,
      "human_validation": {
        "reviewed": false,
        "reviewer_verdict": null,
        "attribution_correct": null,
        "attribution_override": null,
        "missed_claim": false,
        "review_notes": null,
        "review_date": null,
        "reviewer_id": null
      }
    },
    {
      "id": "CC-003",
      "context_type": "strategic_intent",
      "claim_title": "Goal to bring 15 new products to market in five years",
      "claim_description": "Moderna aims to bring 15 new vaccine and drug products to market over the next five years.",
      "source_ids": [
        "S3"
      ],
      "source_quote": "as it attempts to bring 15 new vaccine and drug products over the next five years",
      "verification_status": "verified",
      "verification_confidence": "high",
      "inferred_from": null,
      "apqc_code": null,
      "apqc_name": null,
      "human_validation": {
        "reviewed": false,
        "reviewer_verdict": null,
        "attribution_correct": null,
        "attribution_override": null,
        "missed_claim": false,
        "review_notes": null,
        "review_date": null,
        "reviewer_id": null
      }
    },
    {
      "id": "CC-004",
      "context_type": "organisational",
      "claim_title": "Moderna has thousands of employees",
      "claim_description": "Moderna employs thousands of staff who have access to custom AI chatbots.",
      "source_ids": [
        "S3"
      ],
      "source_quote": "to give its thousands of employees access to custom-built AI chatbots",
      "verification_status": "verified",
      "verification_confidence": "high",
      "inferred_from": null,
      "apqc_code": null,
      "apqc_name": null,
      "human_validation": {
        "reviewed": false,
        "reviewer_verdict": null,
        "attribution_correct": null,
        "attribution_override": null,
        "missed_claim": false,
        "review_notes": null,
        "review_date": null,
        "reviewer_id": null
      }
    },
    {
      "id": "CC-005",
      "context_type": "temporal",
      "claim_title": "Over 10 years of mRNA medicine development experience",
      "claim_description": "Moderna has been working on mRNA medicines for more than 10 years.",
      "source_ids": [
        "S4"
      ],
      "source_quote": "At Moderna, we've been working on mRNA medicines for more than 10 years.",
      "verification_status": "verified",
      "verification_confidence": "high",
      "inferred_from": null,
      "apqc_code": null,
      "apqc_name": null,
      "human_validation": {
        "reviewed": false,
        "reviewer_verdict": null,
        "attribution_correct": null,
        "attribution_override": null,
        "missed_claim": false,
        "review_notes": null,
        "review_date": null,
        "reviewer_id": null
      }
    },
    {
      "id": "CC-006",
      "context_type": "functional",
      "claim_title": "Clinical development and dose selection",
      "claim_description": "Moderna's clinical study teams select and verify vaccine doses before advancing to testing.",
      "source_ids": [
        "S3"
      ],
      "source_quote": "a pilot tool called Dose ID is designed to verify vaccine doses selected by Moderna's clinical study team before the they advance it further in testing",
      "verification_status": "verified",
      "verification_confidence": "high",
      "inferred_from": null,
      "apqc_code": "10383",
      "apqc_name": "Perform clinical studies/trials",
      "human_validation": {
        "reviewed": false,
        "reviewer_verdict": null,
        "attribution_correct": null,
        "attribution_override": null,
        "missed_claim": false,
        "review_notes": null,
        "review_date": null,
        "reviewer_id": null
      }
    },
    {
      "id": "CC-007",
      "context_type": "functional",
      "claim_title": "Legal contract review processes",
      "claim_description": "Moderna's legal team uses AI tools to quickly scan contracts and has been fastest to adopt GPT tools.",
      "source_ids": [
        "S3"
      ],
      "source_quote": "its lawyers quickly scan contracts... So far, its legal team has been the fastest to adopt the tools.",
      "verification_status": "unverified",
      "verification_confidence": "high",
      "inferred_from": null,
      "apqc_code": "10226",
      "apqc_name": "Manage legal and regulatory compliance",
      "human_validation": {
        "reviewed": false,
        "reviewer_verdict": null,
        "attribution_correct": null,
        "attribution_override": null,
        "missed_claim": false,
        "review_notes": null,
        "review_date": null,
        "reviewer_id": null
      }
    },
    {
      "id": "CC-008",
      "context_type": "functional",
      "claim_title": "Drug discovery and research operations",
      "claim_description": "Moderna operates drug research functions including protein targeting, mRNA design, and pre-clinical production.",
      "source_ids": [
        "S3",
        "S4"
      ],
      "source_quote": "tools that help its drug researchers select vaccine doses for testing",
      "verification_status": "verified",
      "verification_confidence": "high",
      "inferred_from": null,
      "apqc_code": "10380",
      "apqc_name": "Perform drug discovery research",
      "human_validation": {
        "reviewed": false,
        "reviewer_verdict": null,
        "attribution_correct": null,
        "attribution_override": null,
        "missed_claim": false,
        "review_notes": null,
        "review_date": null,
        "reviewer_id": null
      }
    },
    {
      "id": "CC-009",
      "context_type": "sectoral",
      "claim_title": "Biotechnology and pharmaceutical industry",
      "claim_description": "Moderna operates in the biotech/pharma sector alongside competitors like Amgen and Genmab who are also adopting generative AI.",
      "source_ids": [
        "S3"
      ],
      "source_quote": "other large drugmakers are incorporating the technology into their employees' processes, too. Amgen and Danish biotech Genmab are both working with OpenAI",
      "verification_status": "verified",
      "verification_confidence": "high",
      "inferred_from": null,
      "apqc_code": null,
      "apqc_name": null,
      "human_validation": {
        "reviewed": false,
        "reviewer_verdict": null,
        "attribution_correct": null,
        "attribution_override": null,
        "missed_claim": false,
        "review_notes": null,
        "review_date": null,
        "reviewer_id": null
      }
    },
    {
      "id": "CC-010",
      "context_type": "products_services",
      "claim_title": "mRNA vaccines and therapeutics pipeline",
      "claim_description": "Moderna develops mRNA vaccines for infectious diseases and therapeutics for cancer, metabolic diseases, and other conditions.",
      "source_ids": [
        "S4"
      ],
      "source_quote": "In addition to mRNA vaccines, Moderna is working on other applications of potential mRNA therapeutics that could help people with cancer, metabolic diseases and more.",
      "verification_status": "verified",
      "verification_confidence": "high",
      "inferred_from": null,
      "apqc_code": null,
      "apqc_name": null,
      "human_validation": {
        "reviewed": false,
        "reviewer_verdict": null,
        "attribution_correct": null,
        "attribution_override": null,
        "missed_claim": false,
        "review_notes": null,
        "review_date": null,
        "reviewer_id": null
      }
    },
    {
      "id": "CC-011",
      "context_type": "organisational",
      "claim_title": "Self-identifies as digital biotech company",
      "claim_description": "Moderna positions itself as 'THE DIGITAL BIOTECH COMPANY' with a technological bent, describing mRNA in software/code language.",
      "source_ids": [
        "S3",
        "S4"
      ],
      "source_quote": "As the DIGITAL BIOTECH COMPANY\u2122, we maximize the utility of mRNA in our proprietary, web-based mRNA DESIGN STUDIO.",
      "verification_status": "verified",
      "verification_confidence": "high",
      "inferred_from": null,
      "apqc_code": null,
      "apqc_name": null,
      "human_validation": {
        "reviewed": false,
        "reviewer_verdict": null,
        "attribution_correct": null,
        "attribution_override": null,
        "missed_claim": false,
        "review_notes": null,
        "review_date": null,
        "reviewer_id": null
      }
    }
  ]
}